New healthcare VC HC9 closes debut fund at $83m

The fund will invest in healthcare software and services start-ups at seed and Series A stages.

  • The fund’s backers include Jory Capital
  • HC9 was founded by Richard Lungen, Jon Gordon and Charlie Falcone
  • HC9 has made three investments: Forge Health, Psych Hub and XP Health

New York’s HC9 Ventures has closed its debut fund at $83 million. The fund will invest in healthcare software and services startups at seed and Series A stages. Its backers include Jory Capital.

HC9, based in Woodstock, has invested in three companies to date: Forge Health, Psych Hub and XP Health.

The firm was founded by general partners Richard Lungen, Jon Gordon and Charlie Falcone. Gordon previously founded and led New York-Presbyterian’s corporate venture arm.

“When we founded HC9, we realized we had an incredible opportunity to build upon the best aspects of venture capital – the financial support it provides for emerging businesses with the potential to transform healthcare – with the insights and relationships from our community,” Lungen said in a statement. “As a result, we can greatly improve the odds of success for the truly transformative businesses we see.”